Abstract: The present application relates to a hydrogel. The hydrogel includes polyvinyl alcohol, sodium carboxymethyl cellulose and Huangshui polysaccharide, and the mass ratio of the mass sum of the polyvinyl alcohol and the sodium carboxymethyl cellulose to the Huangshui polysaccharide is 100:(1.8-8.2). The present application further relates to use of the hydrogel as an adsorbent for a dye. The present application further relates to a method for preparing a hydrogel.

Abstract: A video sequence depicting a person in a medical environment may be obtained and used for determining one or more human models of the person. A first human model representing a first pose or a first body shape of the person may be determined based on a first subset of images from the video sequence, while a second human model representing a second pose or a second body shape of the person may be determined based on a second subset of images from the video sequence. The second 2D or 3D representation of the person may include an adjustment to the first 2D or 3D representation of the person based on the observation of the person provided by the second subset of images.

Abstract: Provided are a bifunctional molecule capable of binding to human transforming growth factor ? (TGF?) and human programmed death-ligand 1 (PD-L1), a pharmaceutical composition comprising the same, and use thereof treating cancer. The bifunctional molecule has high affinity for PD-L1, can significantly promote the secretion of IL-2 and IFN-?, enhances T cell immune responses, and can block TGF? with high specificity, and thus can be used for treating cancer. Also provided is a monoclonal antibody or an antigen-binding fragment thereof binding to human PD-L1.

Abstract: Systems, methods and instrumentalities are described herein for automating a medical environment. The automation may be realized using one or more sensing devices and at least one processing device. The sensing devices may be configured to capture images of the medical environment and provide the images to the processing device. The processing device may determine characteristics of the medical environment based on the images and automate one or more aspects of the operations in the medical environment. These characteristics may include, e.g., people and/or objects present in the images and respective locations of the people and/or objects in the medical environment. The operations that may be automated may include, e.g., maneuvering and/or positioning a medical device based on the location of a patient, determining and/or adjusting the parameters of a medical device, managing a workflow, providing instructions and/or alerts to a patient or a physician, etc.

Abstract: Disclosed are the anti-bacterial activity and the anti-tumor activity of a class of new spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor. The spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor of the present invention, as a class of new anti-bacterial agent, are effective against many antibiotic-resistant Gram-positive strains by inhibiting the activity of the peptide deformylase required in the synthesis of bacterial proteins, and do not affect the synthetic process of the main proteins of the human body, thus selectively killing bacteria.

Abstract: Disclosed are the anti-bacterial activity and the anti-tumor activity of a class of new spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor. The spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor of the present invention, as a class of new anti-bacterial agent, are effective against many antibiotic-resistant Gram-positive strains by inhibiting the activity of the peptide deformylase required in the synthesis of bacterial proteins, and do not affect the synthetic process of the main proteins of the human body, thus selectively killing bacteria.